Distribution of protease resistance-associated mutations among 1,798 antiretroviral-naive HIV-infected patients.

Positive Selection Detection in 40,000 Human Immunodeficiency Virus (HIV) Type 1 Sequences Automatically Identifies Drug Resistance and Positive Fitness Mutations in HIV Protease and Reverse Transcriptase

Lee, Christopher

January 2004

Drug resistance is a major problem in the treatment of AIDS, due to the very high mutation rate of h...

Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil.

Giselle de Faria Romero Soldi
Isadora Coutinho Ribeiro
Cintia Mayumi Ahagon
Luana Portes Ozório Coelho
Gabriela Bastos Cabral
Giselle Ibette Silva López Lopes
João Leandro de Paula Ferreira
Luís Fernando de Macedo Brígido
Salvage Therapy Working Group

January 2019

BACKGROUND:Protease inhibitors (PI) are especially important in salvage therapy. Previous treatment ...

Drug resistance mutations and frequencies among HIV patients in 2011–2013.

Bin Lin (302181)
Xiaoguang Sun (457130)
Shengli Su (4281037)
Cuixia Lv (4281040)
Xiaofei Zhang (136103)
Lin Lin (46073)
Rui Wang (52434)
Jihua Fu (238414)
Dianmin Kang (486843)

July 2017

Note: *indicates second round primer. The drug resistance mutations labeled ‘Other’ indicate that...

Distribution of reverse transcriptase resistance-associated mutations among 1,798 antiretroviral-naive HIV-infected patients.

Sasisopin Kiertiburanakul (427725)
Romanee Chaiwarith (427726)
Sunee Sirivichayakul (7870)
Rossana Ditangco (361612)
Awachana Jiamsakul (427727)
Patrick C. K. Li (427728)
Pacharee Kantipong (311441)
Christopher Lee (11627)
Winai Ratanasuwan (427729)
Adeeba Kamarulzaman (307011)
Annette H. Sohn (427730)
Somnuek Sungkanuparph (427731)

June 2013

Abbreviations: NRTI; nucleoside reverse transcriptase inhibitor, NNRTI; non-nucleoside reverse tr...

Distribution of HIV-1 transmitted drug resistance mutations amongst antiretroviral treatment naïve acute and recently HIV-1 infected MSM volunteers from Coastal Kenya, 2005–2017 (N = 97).

Amin S. Hassan (826967)
Joakim Esbjörnsson (229556)
Elizabeth Wahome (3897763)
Alexander Thiong’o (6095906)
George N. Makau (6095909)
Mathew A. Price (6095912)
Eduard J. Sanders (62291)

December 2018

Distribution of HIV-1 transmitted drug resistance mutations amongst antiretroviral treatment naïve a...

Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease following Different Protease Inhibitor Treatments

January 2002

Although many human immunodeficiency virus type 1 (HIV-1)-infected persons are treated with multiple...

Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments

Wu, Thomas D.
Schiffer, Celia A.
Gonzales, Matthew J.
Taylor, Jonathan
Kantor, Rami
Chou, Sunwen
Israelski, Dennis
Zolopa, Andrew R.
Fessel, W. Jeffrey
Shafer, Robert W.

March 2003

Although many human immunodeficiency virus type 1 (HIV-1)-infected persons are treated with multiple...

Prevalence of Drug Resistance Mutations in HIV-1 ART naïve individuals and HIV-1 and HIV-2 patients under ART.

Isabel Inês M. de Pina-Araujo (555384)
Monick L. Guimarães (309446)
Gonzalo Bello (138839)
Ana Carolina P. Vicente (161799)
Mariza G. Morgado (155854)

April 2014

Prevalence of Drug Resistance Mutations in HIV-1 ART naïve individuals and HIV-1 and HIV-2 patien...

Frequency of HIV-1 drug resistance-associated mutations among 40 sequenced samples.

Arash Memarnejadian (406075)
Shahoo Menbari (737346)
Seyed Ali Mansouri (737347)
Leila Sadeghi (737348)
Rouhollah Vahabpour (737349)
Mohammad Reza Aghasadeghi (572528)
Ehsan Mostafavi (406077)
Mohammad Abdi (737350)

May 2015

SDRMs, surveillance drug-resistant mutations; NRTIs, nucleoside reverse transcriptase inhibitors;...

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database-0

Jean Ruelle (80726)
François Roman (80727)
Anne-Thérèse Vandenbroucke (80728)
Christine Lambert (80729)
Katrien Fransen (80730)
Fedoua Echahidi (80731)
Denis Piérard (80732)
Chris Verhofstede (80733)
Kristel Van Laethem (80734)
Marie-Luce Delforge (80735)
Dolorès Vaira (80736)
Jean-Claude Schmit (80737)
Patrick Goubau (80738)

December 2011

Idue where variability was found in ARV-naïve patients. (N): number of samples from naïve patients h...

Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes.

Charlotte Charpentier
Sidonie Lambert-Niclot
Claudia Alteri
Alexandre Storto
Philippe Flandre
Valentina Svicher
Carlo-Federico Perno
Françoise Brun-Vézinet
Vincent Calvez
Anne-Geneviève Marcelin
Francesca Ceccherini-Silberstein
Diane Descamps

OBJECTIVE: To describe the prevalence of the L76V protease inhibitors resistance-associated mutation...

Prevalence of Transmitted Drug Resistance Mutations in HIV-1-Infected Drug-Naive Patients from Urban and Suburban Regions of Kenya

Onsongo, Simon
Abidi, Syed Hani
Khamadi, Samoel
Shah, Reena
Kageha, Sheila
Ojwang, Peter
Ali, Syed
Okinda, Nancy

January 2016

HIV was first described in Kenya in 1984-1985. Currently, Kenya has an estimated HIV-1 prevalence of...

Prevalence of the L76V mutation between 1998 and 2010 in a database containing 29,643 sequences issued from clinical samples with any antiretroviral drug resistance.

Charlotte Charpentier (49588)
Sidonie Lambert-Niclot (288018)
Claudia Alteri (288019)
Alexandre Storto (288021)
Philippe Flandre (204722)
Valentina Svicher (103599)
Carlo-Federico Perno (82892)
Françoise Brun-Vézinet (131084)
Vincent Calvez (243389)
Anne-Geneviève Marcelin (247377)
Francesca Ceccherini-Silberstein (103660)
Diane Descamps (266281)

February 2013

Prevalence of the L76V mutation between 1998 and 2010 in a database containing 29,643 sequences i...

Description of the L76V Resistance Protease Mutation in HIV-1 B and “Non-B” Subtypes

Charpentier, Charlotte
Lambert-Niclot, Sidonie
Alteri, Claudia
Storto, Alexandre
Flandre, Philippe
Svicher, Valentina
Perno, Carlo-Federico
Brun-Vézinet, Francoise
Calvez, Vincent
Marcelin, Anne-Geneviève
Ceccherini-Silberstein, Francesca
Descamps, Diane

January 2013

International audienceObjective: To describe the prevalence of the L76V protease inhibitors resistan...

Distribution of genotypic drug resistance mutations for patients with virologic failure on second-line ART in a large ART roll-out program in South Africa.

Julie H. Levison (329556)
Catherine Orrell (93992)
Sébastien Gallien (5652268)
Daniel R. Kuritzkes (214840)
Naishin Fu (329562)
Elena Losina (195874)
Kenneth A. Freedberg (188623)
Robin Wood (4924)

February 2013

ART: antiretroviral treatment. PI: protease inhibitor. NRTI: nucleoside reverse transcriptase inh...

Positive Selection Detection in 40,000 Human Immunodeficiency Virus (HIV) Type 1 Sequences Automatically Identifies Drug Resistance and Positive Fitness Mutations in HIV Protease and Reverse Transcriptase

Lee, Christopher

January 2004

Drug resistance is a major problem in the treatment of AIDS, due to the very high mutation rate of h...

Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil.

Giselle de Faria Romero Soldi
Isadora Coutinho Ribeiro
Cintia Mayumi Ahagon
Luana Portes Ozório Coelho
Gabriela Bastos Cabral
Giselle Ibette Silva López Lopes
João Leandro de Paula Ferreira
Luís Fernando de Macedo Brígido
Salvage Therapy Working Group

January 2019

BACKGROUND:Protease inhibitors (PI) are especially important in salvage therapy. Previous treatment ...

Drug resistance mutations and frequencies among HIV patients in 2011–2013.

Bin Lin (302181)
Xiaoguang Sun (457130)
Shengli Su (4281037)
Cuixia Lv (4281040)
Xiaofei Zhang (136103)
Lin Lin (46073)
Rui Wang (52434)
Jihua Fu (238414)
Dianmin Kang (486843)

July 2017

Note: *indicates second round primer. The drug resistance mutations labeled ‘Other’ indicate that...

Distribution of reverse transcriptase resistance-associated mutations among 1,798 antiretroviral-naive HIV-infected patients.

Sasisopin Kiertiburanakul (427725)
Romanee Chaiwarith (427726)
Sunee Sirivichayakul (7870)
Rossana Ditangco (361612)
Awachana Jiamsakul (427727)
Patrick C. K. Li (427728)
Pacharee Kantipong (311441)
Christopher Lee (11627)
Winai Ratanasuwan (427729)
Adeeba Kamarulzaman (307011)
Annette H. Sohn (427730)
Somnuek Sungkanuparph (427731)

June 2013

Abbreviations: NRTI; nucleoside reverse transcriptase inhibitor, NNRTI; non-nucleoside reverse tr...

Distribution of HIV-1 transmitted drug resistance mutations amongst antiretroviral treatment naïve acute and recently HIV-1 infected MSM volunteers from Coastal Kenya, 2005–2017 (N = 97).

Amin S. Hassan (826967)
Joakim Esbjörnsson (229556)
Elizabeth Wahome (3897763)
Alexander Thiong’o (6095906)
George N. Makau (6095909)
Mathew A. Price (6095912)
Eduard J. Sanders (62291)

December 2018

Distribution of HIV-1 transmitted drug resistance mutations amongst antiretroviral treatment naïve a...

Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease following Different Protease Inhibitor Treatments

January 2002

Although many human immunodeficiency virus type 1 (HIV-1)-infected persons are treated with multiple...

Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments

Wu, Thomas D.
Schiffer, Celia A.
Gonzales, Matthew J.
Taylor, Jonathan
Kantor, Rami
Chou, Sunwen
Israelski, Dennis
Zolopa, Andrew R.
Fessel, W. Jeffrey
Shafer, Robert W.

March 2003

Although many human immunodeficiency virus type 1 (HIV-1)-infected persons are treated with multiple...

Prevalence of Drug Resistance Mutations in HIV-1 ART naïve individuals and HIV-1 and HIV-2 patients under ART.

Isabel Inês M. de Pina-Araujo (555384)
Monick L. Guimarães (309446)
Gonzalo Bello (138839)
Ana Carolina P. Vicente (161799)
Mariza G. Morgado (155854)

April 2014

Prevalence of Drug Resistance Mutations in HIV-1 ART naïve individuals and HIV-1 and HIV-2 patien...

Frequency of HIV-1 drug resistance-associated mutations among 40 sequenced samples.

Arash Memarnejadian (406075)
Shahoo Menbari (737346)
Seyed Ali Mansouri (737347)
Leila Sadeghi (737348)
Rouhollah Vahabpour (737349)
Mohammad Reza Aghasadeghi (572528)
Ehsan Mostafavi (406077)
Mohammad Abdi (737350)

May 2015

SDRMs, surveillance drug-resistant mutations; NRTIs, nucleoside reverse transcriptase inhibitors;...

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database-0

Jean Ruelle (80726)
François Roman (80727)
Anne-Thérèse Vandenbroucke (80728)
Christine Lambert (80729)
Katrien Fransen (80730)
Fedoua Echahidi (80731)
Denis Piérard (80732)
Chris Verhofstede (80733)
Kristel Van Laethem (80734)
Marie-Luce Delforge (80735)
Dolorès Vaira (80736)
Jean-Claude Schmit (80737)
Patrick Goubau (80738)

December 2011

Idue where variability was found in ARV-naïve patients. (N): number of samples from naïve patients h...

Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes.

Charlotte Charpentier
Sidonie Lambert-Niclot
Claudia Alteri
Alexandre Storto
Philippe Flandre
Valentina Svicher
Carlo-Federico Perno
Françoise Brun-Vézinet
Vincent Calvez
Anne-Geneviève Marcelin
Francesca Ceccherini-Silberstein
Diane Descamps

OBJECTIVE: To describe the prevalence of the L76V protease inhibitors resistance-associated mutation...

Prevalence of Transmitted Drug Resistance Mutations in HIV-1-Infected Drug-Naive Patients from Urban and Suburban Regions of Kenya

Onsongo, Simon
Abidi, Syed Hani
Khamadi, Samoel
Shah, Reena
Kageha, Sheila
Ojwang, Peter
Ali, Syed
Okinda, Nancy

January 2016

HIV was first described in Kenya in 1984-1985. Currently, Kenya has an estimated HIV-1 prevalence of...

Prevalence of the L76V mutation between 1998 and 2010 in a database containing 29,643 sequences issued from clinical samples with any antiretroviral drug resistance.

Charlotte Charpentier (49588)
Sidonie Lambert-Niclot (288018)
Claudia Alteri (288019)
Alexandre Storto (288021)
Philippe Flandre (204722)
Valentina Svicher (103599)
Carlo-Federico Perno (82892)
Françoise Brun-Vézinet (131084)
Vincent Calvez (243389)
Anne-Geneviève Marcelin (247377)
Francesca Ceccherini-Silberstein (103660)
Diane Descamps (266281)

February 2013

Prevalence of the L76V mutation between 1998 and 2010 in a database containing 29,643 sequences i...

Description of the L76V Resistance Protease Mutation in HIV-1 B and “Non-B” Subtypes

Charpentier, Charlotte
Lambert-Niclot, Sidonie
Alteri, Claudia
Storto, Alexandre
Flandre, Philippe
Svicher, Valentina
Perno, Carlo-Federico
Brun-Vézinet, Francoise
Calvez, Vincent
Marcelin, Anne-Geneviève
Ceccherini-Silberstein, Francesca
Descamps, Diane

January 2013

International audienceObjective: To describe the prevalence of the L76V protease inhibitors resistan...

Distribution of genotypic drug resistance mutations for patients with virologic failure on second-line ART in a large ART roll-out program in South Africa.

Julie H. Levison (329556)
Catherine Orrell (93992)
Sébastien Gallien (5652268)
Daniel R. Kuritzkes (214840)
Naishin Fu (329562)
Elena Losina (195874)
Kenneth A. Freedberg (188623)
Robin Wood (4924)

February 2013

ART: antiretroviral treatment. PI: protease inhibitor. NRTI: nucleoside reverse transcriptase inh...

Positive Selection Detection in 40,000 Human Immunodeficiency Virus (HIV) Type 1 Sequences Automatically Identifies Drug Resistance and Positive Fitness Mutations in HIV Protease and Reverse Transcriptase

Lee, Christopher

January 2004

Drug resistance is a major problem in the treatment of AIDS, due to the very high mutation rate of h...

Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil.

Giselle de Faria Romero Soldi
Isadora Coutinho Ribeiro
Cintia Mayumi Ahagon
Luana Portes Ozório Coelho
Gabriela Bastos Cabral
Giselle Ibette Silva López Lopes
João Leandro de Paula Ferreira
Luís Fernando de Macedo Brígido
Salvage Therapy Working Group

January 2019

BACKGROUND:Protease inhibitors (PI) are especially important in salvage therapy. Previous treatment ...

Drug resistance mutations and frequencies among HIV patients in 2011–2013.

Bin Lin (302181)
Xiaoguang Sun (457130)
Shengli Su (4281037)
Cuixia Lv (4281040)
Xiaofei Zhang (136103)
Lin Lin (46073)
Rui Wang (52434)
Jihua Fu (238414)
Dianmin Kang (486843)

July 2017

Note: *indicates second round primer. The drug resistance mutations labeled ‘Other’ indicate that...

Distribution of protease resistance-associated mutations among 1,798 antiretroviral-naive HIV-infected patients.

Abstract

Extracted data

Distribution of protease resistance-associated mutations among 1,798 antiretroviral-naive HIV-infected patients.

Abstract

Extracted data

Related items

Related items